Latigo Biotherapeutics, Inc. (NASDAQ:LTGO)

US · Delayed Price · Currency is USD

22.15+0.61 (+2.83%)

Market Cap	1.33B+23.1%
Revenue (ttm)	n/a
Net Income	n/a
EPS	n/a
Shares Out	60.15M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	178,712
Open	21.76
Previous Close	21.54
Day's Range	21.50 - 23.22
52-Week Range	17.22 - 25.93
Beta	n/a
Analysts	n/a
Price Target	52.25(+135.89%)
Earnings Date	n/a

Full Chart

Alerts Compare

About LTGO

Latigo Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company committed to developing innovative non-opioid pain medicines designed to rapidly and effectively stop the transmission of pain without the risk of addiction. Its products include Molecule: LTG-001, Molecule: LTG-32, Molecule: LTG-001 IV and Molecule: LTG-418. The company was founded on November 20, 2018 and is headquartered in Thousand Oak, CA.

Address

1300 Rancho Conejo Boulevard, Suite 305, Thousand Oak, CA, 91320, US

Market Cap

1.33 billion

Employees

Industrial Classification

Medical - Pharmaceuticals

What Are Insiders Doing?

Open-market buy / sell balanceNet Buying

Sold

Bought

$2.52M

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

1 Day

+2.83%

5 Days

-2.34%

1 Month

+19.60%

6 Months

+23.06%

1 Year

+23.06%

$LTGO stock is featured in our Insider Score Rankings, and Insider Trades datasets.

→ All Stock Lists

Whale Activity →

Recently reported changes in LTGO holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by LTGO's directors and management

Source: SEC EDGAR (Form 4)

Corporate Lobbying

LTGO Estimated quarterly lobbying spending

Source: U.S. Senate LDA

U.S. Patents

New LTGO patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to LTGO from public contracts

Source: USAspending.gov

LTGO Insider Score

Our composite score: insider buying, sector, volume, tone & dilution

Members only

The live Insider Score for LTGO is included with Insider Access.

Unlock Insider Score

Bull Case vs Bear Case

AI-generated from LTGO’s recent data — informational, not investment advice

Generating analysis…

Insider Score

Our 0–100 Insider Score and the signals behind it.

Members only

The live Insider Score and its full factor breakdown are included with Insider Access.

Unlock Insider Score

Recent Insider Activity

Buys

Sells

Buy Value

$2.52M

Distinct Buyers

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.